Cialis growth graph moves upwards

There are 30 million cases of ED in Europe and more than half the men over 40 suffer from it worldwide, only 10 to 15 per cent of them seek treatment. More men have already started consulting doctors, especially since ED is treatable at any stage. There is also a high prevalence of ED in co morbid medical conditions and in risk factors such as cardiovascular diseases, hypertension, dyslipidemia and depression.

The ED market has grown 3.5% from 2004 to 2005. This growth is completely due to the sale of three brands – Viagra, Cialis and Levitra. Experts feel that PDE-5 inhibitors will remain the mainstay of ED treatment as all the three Viagra, Cialis and Levitra have excellent efficacy and safety profile.

Cialis has shown an incredible growth in the market share ousting the long dominance of Viagra in several markets including the US. Cialis sale has been more than expected this year. Cialis sales touched a record sale of $955 million to $965 million worldwide for 2006. This is much higher to the estimated sales of $920 million to $950 million.

In the U.S., market share of total prescriptions of Cialis reached 26.1% in June 2006, an increase of 2.8 percentage points from June 2005. Across Europe, Canada, and Mexico, Cialis captured 34.4% of aggregate market share in May 2006, an increase of 3.5 percentage points from May 2005. For the 2006 second quarter, the U.S. ED market grew 3.3%, compared to the second quarter of 2005.

The ED market still has place for new entries even though the market is dominated by Viagra and Cialis. Developing treatments for niche patients can provide an opportunity for new ED drugs. This could be diabetes related ED or prostatectomy patients or ED due to cardiovascular disease. This chronic treatment of ED may require once-daily dosing and hence provides companies to explore more avenues.

ICOS has already submitted a new drug application to the Food and Drug Administration for a lower-dose, once-a-day formulation of Cialis for impotence, which could enable a man to always be ready for intercourse. The drug is also being tested in patients with enlarged prostates, and in pulmonary arterial hypertension.

In its press release the officials of ICOS said, "We are excited about the potential for Cialis as a once-a-day treatment for ED". "The ED medical experts that we have consulted with are enthusiastic about the possibility that Cialis Once-A-Day could provide a welcome alternative for the man with ED who takes a PDE5 inhibitor more frequently than average. In market research, patients with ED have expressed interest in the possibility of treating this chronic condition with a once-daily tablet."

Cialis is well tolerated and the most commonly reported side effects with Cialis are headache, upset stomach, nasal congestion, backache, muscle ache, dizziness and flushing. The adverse events reported with Cialis were transient and generally mild or moderate. As with other PDE5 inhibitors, the use of Cialis is contraindicated in patients who are taking nitrates or for those who have cardiac disease and for whom sexual activity is not advisable. The use of a specific type of alpha blocker, alpha (1) blockers like doxazosin, is not recommended due to the possibility of lowering blood pressure to unsafe levels in some men.

It is extremely easy to buy Cialis online or from a Cialis pharmacy online, Cialis should not be used without doctors’ prescription. Cialis is a prescription drug and a thorough checkup is required before you can take Cialis. A number of cheap Cialis pharmacies can provide discount Cialis online costing much less than the Cialis available in pharmacies; Cialis is a prescription drug and should not be taken without doctor’s prescription. These drugs have serious side effects and should be taken only after a one to one interaction with the doctor.